BSE · BIOGEN

BIOGEN PHARMACHEM INDUSTRIES LIMITED

Sector: Financial Services · ISIN: INE703D01023

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,758

of 5,004 stocks

🏆 New peak

▲ 571W

Peak #3,758 · 01 Oct 2026

A microcap name in Financial Services, BIOGEN PHARMACHEM INDUSTRIES LIMITED is growing revenue rapidly, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 0%. Ownership as of Jun 2026.

Market Cap

29.49 Cr

P/E Ratio

28.00

P/B Ratio

0.25

ROE

0.87%

ROCE

0.96%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	44.34 L	57.82 L	Rs 0	Rs 0
Net Profit	22.14 L	-35.88 L	46.23 L	-49.16 L
EPS	0.00	0.00	0.01	0.01
Operating Profit	22.14 L	-35.88 L	46.23 L	-49.16 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

0.00%

Public

100.00%

PUBLIC BREAKDOWN

DII

0.00%

Individuals

71.97%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
15 May 2026	Bonus	Bonus issue 1:6
15 Jul 2003	Split	Sub Division of Equity shares

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs